Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP50568.RAa4MXDSiHSmHw5uoge3UULgkiUp6KxRUHizEZfC0BViA130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50568.RAa4MXDSiHSmHw5uoge3UULgkiUp6KxRUHizEZfC0BViA130_provenance.
• assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP80349.RAdZhaBxfCgp-NzlMwWtras5ZE_MEUrdgLkCMyOBqD2i4130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP80349.RAdZhaBxfCgp-NzlMwWtras5ZE_MEUrdgLkCMyOBqD2i4130_provenance.
• assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP50831.RAnAv7eFh_5DRp_i2GK_DW1BuE28c-KAQfFT_tlYW67Og130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50831.RAnAv7eFh_5DRp_i2GK_DW1BuE28c-KAQfFT_tlYW67Og130_provenance.
• assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP77258.RAuUr8C4x20GTkvpmuEzXB9CLwDJiTNMhAFlejE6k8axM130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP77258.RAuUr8C4x20GTkvpmuEzXB9CLwDJiTNMhAFlejE6k8axM130_provenance.
• NP79338.RAr4hhUfKM65eZZnycSTaDxqPk9HDZJQevxO1lfwBDbTA130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP79338.RAr4hhUfKM65eZZnycSTaDxqPk9HDZJQevxO1lfwBDbTA130_provenance.
• assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP61444.RACv50vV39Cz9f3FT9WVsHOLt2UqOUQKAdd6pr2pVkECo130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP61444.RACv50vV39Cz9f3FT9WVsHOLt2UqOUQKAdd6pr2pVkECo130_provenance.
• NP177852.RAUzm0YY7XsvSVPVRIeiXeV2k4U7P-x5Ckr1ZoJb74AWA130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177852.RAUzm0YY7XsvSVPVRIeiXeV2k4U7P-x5Ckr1ZoJb74AWA130_provenance.
• NP177854.RAe5LAA0ULePAZ-HYUpPcl8CIqn6Rpq02RUDpMmpW2EQ4130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177854.RAe5LAA0ULePAZ-HYUpPcl8CIqn6Rpq02RUDpMmpW2EQ4130_provenance.
• NP177856.RAVF64SjJHEvcK7xjNraJ0OxiHVGhGmOLnj7QUvF2LJvA130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177856.RAVF64SjJHEvcK7xjNraJ0OxiHVGhGmOLnj7QUvF2LJvA130_provenance.
• NP177859.RAbjNPAJz76sE9PpVkATH88cdmyaMLbK8U0KRZOOUBEHc130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177859.RAbjNPAJz76sE9PpVkATH88cdmyaMLbK8U0KRZOOUBEHc130_provenance.
• NP177864.RARpfJ6KXLrXdeNu_zUrBrN1tbzdBlz-QjoMw2WXyRWOY130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177864.RARpfJ6KXLrXdeNu_zUrBrN1tbzdBlz-QjoMw2WXyRWOY130_provenance.
• NP102422.RAABma8-SKFB11C1p0-2clWGQBnxhf20zrRSqfdNPjF3g130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP102422.RAABma8-SKFB11C1p0-2clWGQBnxhf20zrRSqfdNPjF3g130_provenance.
• NP53604.RA1PF1q6tvNpTfmnDbNmir_pvvXiz-Lih4vKE92WO5oUU130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP53604.RA1PF1q6tvNpTfmnDbNmir_pvvXiz-Lih4vKE92WO5oUU130_provenance.
• NP177857.RAiAXFrwwUbCrFR15yZWnhPgbKT8ViffXQG_0PrJM6GUo130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177857.RAiAXFrwwUbCrFR15yZWnhPgbKT8ViffXQG_0PrJM6GUo130_provenance.
• NP80662.RA0MRmbcIBu31lNEbcOhrzxKbseC5CJYwOrXTBeEId_FU130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP80662.RA0MRmbcIBu31lNEbcOhrzxKbseC5CJYwOrXTBeEId_FU130_provenance.
• NP53711.RANjaXuDdWV6Xlxdk_SasUOj4kgyo6MSTmu02zjT_MqtU130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP53711.RANjaXuDdWV6Xlxdk_SasUOj4kgyo6MSTmu02zjT_MqtU130_provenance.
• NP77413.RAMLZ5qK4bBLzXBEJ7pquhEHp8fS8RG7cA8O5B901tST4130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP77413.RAMLZ5qK4bBLzXBEJ7pquhEHp8fS8RG7cA8O5B901tST4130_provenance.
• NP92165.RAx718NbKFN9nnuIjDQJavoB1y0wv8i39eG3DnAiIxv_s130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92165.RAx718NbKFN9nnuIjDQJavoB1y0wv8i39eG3DnAiIxv_s130_provenance.
• NP111457.RAFVwhbpnP_gWIxekXB-WqftyLFXm-kJBCy4sE0M4y7WI130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111457.RAFVwhbpnP_gWIxekXB-WqftyLFXm-kJBCy4sE0M4y7WI130_provenance.
• NP136365.RAMJUlszuinx7YNT3N9enlQJcNz_MaYRZCzGA2UY0VfrY130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP136365.RAMJUlszuinx7YNT3N9enlQJcNz_MaYRZCzGA2UY0VfrY130_provenance.
• NP177855.RAI9O_8YhUlPd8PFQpP_0lyCaKIXnEjYojYbme5nekYFY130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177855.RAI9O_8YhUlPd8PFQpP_0lyCaKIXnEjYojYbme5nekYFY130_provenance.
• NP177862.RAIOKnGxRrBceLxhUFzMPf63hLFii4luCarfXAceXOXZo130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177862.RAIOKnGxRrBceLxhUFzMPf63hLFii4luCarfXAceXOXZo130_provenance.
• NP177853.RA3y0vcALCyPEX5benC_ceACots7MX4FJht0KRfUywT3U130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177853.RA3y0vcALCyPEX5benC_ceACots7MX4FJht0KRfUywT3U130_provenance.
• NP177858.RA_53V681nimpWd2kWHeVb8NOgDspAG5sLPX_U9j4Iu4w130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177858.RA_53V681nimpWd2kWHeVb8NOgDspAG5sLPX_U9j4Iu4w130_provenance.
• NP177860.RA5hzT_-G5DYrk19obVMvAa5se0F2diadTb4GyNX07BKE130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177860.RA5hzT_-G5DYrk19obVMvAa5se0F2diadTb4GyNX07BKE130_provenance.
• NP177865.RAxzjvEQbV-Y-c9f5yTgtXch3m05L1MAROMsxPVEn2250130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177865.RAxzjvEQbV-Y-c9f5yTgtXch3m05L1MAROMsxPVEn2250130_provenance.